SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 136 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $7,000 | -84.8% | 60,995 | +126.7% | 0.00% | – |
Q3 2018 | $46,000 | -47.7% | 26,904 | -47.1% | 0.00% | -100.0% |
Q2 2018 | $88,000 | +183.9% | 50,846 | +203.6% | 0.00% | – |
Q1 2018 | $31,000 | -24.4% | 16,748 | -10.0% | 0.00% | – |
Q4 2017 | $41,000 | -63.1% | 18,600 | -51.3% | 0.00% | -100.0% |
Q3 2017 | $111,000 | +13.3% | 38,232 | +73.8% | 0.00% | 0.0% |
Q2 2017 | $98,000 | +6.5% | 22,002 | +11.8% | 0.00% | 0.0% |
Q1 2017 | $92,000 | -81.5% | 19,673 | -75.9% | 0.00% | -75.0% |
Q4 2016 | $497,000 | +137.8% | 81,652 | +115.7% | 0.00% | +100.0% |
Q3 2016 | $209,000 | -95.6% | 37,859 | -97.0% | 0.00% | -94.1% |
Q2 2016 | $4,729,000 | +35.2% | 1,244,557 | -1.8% | 0.03% | +36.0% |
Q1 2016 | $3,498,000 | +2216.6% | 1,267,412 | +4358.3% | 0.02% | +2400.0% |
Q3 2015 | $151,000 | +277.5% | 28,428 | +117.9% | 0.00% | – |
Q4 2014 | $40,000 | -42.9% | 13,048 | -23.6% | 0.00% | – |
Q2 2014 | $70,000 | +6.1% | 17,079 | +18.9% | 0.00% | – |
Q3 2013 | $66,000 | – | 14,365 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |